RSS-Feed abonnieren
DOI: 10.1055/s-0038-1669440
Occult Placenta Accreta: Risk Factors, Adverse Obstetrical Outcomes, and Recurrence in Subsequent Pregnancies
Publikationsverlauf
19. November 2017
11. Juli 2018
Publikationsdatum:
05. September 2018 (online)


Abstract
Objective To assess the risk factors, adverse obstetrical outcomes, and recurrence risk associated with pathologically diagnosed occult placenta accreta.
Study Design This was a retrospective observational study of clinically adherent placentas requiring manual extraction that underwent pathological examination. Cases were defined as those with histological evidence of placenta accreta, and controls were defined as those without accreta. All subsequent pregnancies were evaluated to determine the recurrence risk of occult accreta in future pregnancies.
Results Of 491 women with clinically adherent placentas, 100 (20.1%) with a pathological diagnosis of occult accreta were compared with 391 (79.9%) without occult accreta. In bivariable analysis, risk factors associated with occult accreta included a history of previous cesarean (19 vs. 10.7%; p = 0.03) and prior uterine surgery (35 vs. 19.7%; p = 0.001). Adverse obstetrical outcomes were more common in women with occult accreta including postpartum hemorrhage (59 vs. 31.7%; p < 0.001) and peripartum hysterectomy (21 vs. 0.3%; p < 0.001). In 130 subsequent pregnancies, there was an increased risk of retained placenta (42.9 vs. 19%; p = 0.04) and recurrence of occult accreta (29.6 vs. 6.8%; p = 0.05).
Conclusion Occult accreta is associated with an increased risk of hemorrhagic morbidity and recurrence of morbidly adherent placenta in subsequent pregnancies.
Keywords
retained placenta - focal accreta - postpartum hemorrhage - placental pathology - occult accretas - histological accretaCondensation
Occult placenta accreta is associated with significant hemorrhagic morbidity and recurrence in future pregnancies.
Note
This paper was presented in a poster format at the 2017 Annual Clinical and Scientific Meeting of the American College of Obstetricians and Gynecologists, San Diego, CA, May 6 to 9, 2017.